Early diagnosis of dementia is crucial for effective intervention. This study focuses on using biomarkers from cerebrospinal fluid, blood, neuropsychological tests, neuroimaging, and digital speech processing to predict dementia in individuals with MCI. By integrating these data, high-risk individuals can be identified for personalised prevention plans.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.